WallStSmart
BCAX

Bicara Therapeutics Inc. Common Stock

NASDAQ: BCAX · HEALTHCARE · BIOTECHNOLOGY

$21.28
-2.92% today

Updated 2026-04-29

Market cap
$1.40B
P/E ratio
P/S ratio
EPS (TTM)
$-2.52
Dividend yield
52W range
$8 – $24
Volume
0.6M

Bicara Therapeutics Inc. Common Stock (BCAX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 7
Last 7 quarters
Avg EPS surprise
-23.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-74.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+13.4%
2025-08-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.68-4.0%$18.68$18.37-1.7%
2025-11-10$-0.67-25.5%$14.64$14.73+0.6%
2025-08-12$-0.50+6.8%$9.99$11.33+13.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.65$-0.68-4.0%
2025-09-30$-0.53$-0.67-25.5%
2025-06-30$-0.54$-0.50+6.8%
2025-03-31$-0.40$-0.68-70.9%
2024-12-31$-0.28$-0.39-38.1%
2024-09-30$-0.50$-1.60-220.0%
2024-06-30$-0.43$-0.45-4.7%

Frequently asked questions

Has Bicara Therapeutics Inc. Common Stock beaten earnings estimates?
Bicara Therapeutics Inc. Common Stock has beaten Wall Street EPS estimates in 1 of its last 7 quarterly reports, with an average EPS surprise of -23.4% over the last 4 quarters.
How does BCAX stock react to earnings?
BCAX stock has moved an average of +4.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.